Top 50 Clinical Trial Platform - Series A

The startup offers a remote patient research platform that integrates validated studies and connects with wearables and medical devices, facilitating seamless data transfer into existing systems. This technology enables biopharma and home health professionals to efficiently design and scale clinical research programs while ensuring compliance with data requirements.

The startup offers a cloud-based platform that streamlines patient identification and recruitment for clinical trials through a plug-and-play setup and a user-friendly video portal. This technology enables pharmaceutical companies and research institutions to efficiently qualify and enroll suitable participants, significantly reducing the time and cost associated with trial recruitment.

Power Life Science is a platform that connects patients with over 30,000 active clinical trials, allowing them to filter options based on specific medical conditions, locations, and drug types. This service addresses the challenge of limited access to experimental treatments by streamlining the search process and facilitating direct connections with researchers.

Inato has developed a global clinical trial marketplace that connects pharmaceutical sponsors with community-based research sites, enhancing patient access to clinical trials. By streamlining site selection and enrollment processes, Inato addresses the limited participation opportunities for diverse patient populations, ultimately accelerating the pace of medical research.

R.grid provides an AI-driven automation platform that integrates trial management processes from pre-trial to trial close, significantly reducing administrative errors and delays. Its products, Inclusive and TrialEngine, streamline patient recruitment and automate complex workflows, cutting trial timelines by months and enhancing overall trial success rates.

Florence Healthcare provides a Site Enablement Platform that automates document workflows and participant enrollment for clinical trials, enhancing collaboration among sponsors, CROs, and research sites. By connecting over 20,000 research sites globally, the platform streamlines clinical research processes, reducing operational risks and accelerating trial timelines.

This company provides a Proof-as-a-Service model for generating large-scale, diverse clinical trial data for wellness products. They utilize adaptive trial formats and integrated biomarkers to deliver precision health insights rapidly. This evidence supports stronger product claims, optimized formulations, and improved consumer targeting.

Clara Health provides a digital platform that connects patients with clinical trials tailored to their specific health needs, utilizing 24/7 live patient navigators for personalized support. The service addresses the challenge of accessing relevant clinical studies, ensuring patients can find and participate in research that offers new treatment options at no cost.

Macro Trials provides sponsors and CROs with a network of high-performing, research-experienced clinical sites specializing in ophthalmology, dermatology, and pulmonology. The company utilizes a centralized hub and spoke model to rapidly activate sites, maintain protocol discipline, and ensure reliable enrollment in diverse communities. This turnkey operation manages all site infrastructure, allowing clinicians to focus on patient care while delivering consistent, high-quality data for Phase 2 and beyond studies.

Mural Health provides an integrated platform for clinical trial participant management, streamlining operations for sponsors and sites. The platform facilitates participant engagement through flexible payment options, integrated travel coordination, and direct communication tools. This results in improved participant retention, streamlined administrative tasks, and access to real-time analytics for better trial outcomes.

Faro Health provides an AI-enabled platform for designing and implementing clinical trial protocols, streamlining the complexities of protocol development through data-driven insights and reusable content. This technology reduces authoring time and enhances the quality of clinical trials, minimizing patient burden and associated costs.

Korio is a Randomization and Trial Supply Management (RTSM) platform that enhances clinical trial efficiency by providing flexible, customizable solutions that adapt to complex study designs. It addresses delays and quality issues caused by rigid legacy systems, ensuring timely updates and reliable support throughout the trial process.

Trial Library develops a technology-enabled platform that enhances patient recruitment and diversity in oncology clinical trials through community provider engagement and personalized navigation services. By addressing the lack of equitable representation in cancer research, the platform facilitates access to precision medicine for underrepresented patient populations, improving enrollment rates and health outcomes.

Hawthorne Health operates a nationwide network of community-based sites and offers home visit solutions to bring clinical trials closer to patients. This model aims to accelerate patient enrollment, improve retention, and enhance protocol compliance across diverse therapeutic areas. The company leverages experienced investigators and technology to execute studies and generate high-quality data for sponsors.

Medrio provides a cloud‑based, no‑code platform that integrates electronic data capture, randomization and trial supply management, ePRO and eConsent into a single validated solution. The system enables sponsors and CROs to configure and launch studies in weeks, apply mid‑study amendments without downtime, and maintain real‑time, audit‑ready data across sites. Built‑in ISO 9001, GDPR and 21 CFR Part 11 compliance and 24/7 support help reduce operational costs and accelerate trial timelines.

The startup has developed a digitized clinical development platform that streamlines the clinical trial process by managing complex metadata challenges in the biopharma industry. This platform minimizes deployment risks and system downtime, enhancing the quality of medical research and accelerating the delivery of new therapies to patients.

Topography Health provides a research platform that integrates cutting-edge technology with tailored staffing services to enhance clinical trials. The company supports community physicians and investigators to scale research, improving speed, quality, and diversity in trial participation. This patient-centered, community-based infrastructure increases patient access to novel therapies within their trusted provider network.

Clinical Research IO develops eSource technology that enhances protocol compliance and eliminates transcription errors in clinical trials. This platform significantly reduces audit risk by 70% and increases patient enrollment by 39%, saving time and costs for research sites and sponsors.

PhaseV develops a machine learning-based platform that utilizes causal inference and multi-arm bandit algorithms to optimize adaptive clinical trial design and execution. This technology enhances decision-making and resource allocation, increasing the success rates of clinical trials by providing real-time, data-driven insights throughout the trial process.

Triomics is a generative AI platform that matches patients to clinical trials by analyzing health records and medical terminology. This technology alleviates the cognitive overload faced by healthcare staff, accelerating trial enrollment and improving oncology care operations.

ObjectiveHealth operates a data analytics and machine learning platform that enhances clinical decision-making by extracting actionable insights from real-world evidence. The platform targets inefficiencies in healthcare delivery, aiming to improve patient outcomes through informed treatment strategies.

HealthMatch is a platform that connects patients with eligible clinical trials for new drugs and treatments by simplifying the search process and assessing trial eligibility. This service addresses the challenge of finding appropriate clinical studies, enabling patients to access potential therapies that may not be widely available.

Clinetic provides a technology platform that connects clinical research teams with a network of over 20 million patients across 70+ hospitals, facilitating faster patient identification, engagement, and enrollment for studies. By streamlining prospective real-world studies through protocol-specific patient alignment and hybrid study implementation, Clinetic enhances the efficiency and speed of clinical research processes.

SubjectWell is a patient recruitment platform that utilizes machine learning to match healthcare-motivated patients with clinical studies across various therapeutic areas, ensuring a diverse and pre-qualified patient pool. By streamlining the connection between sponsors, CROs, and patients, SubjectWell reduces the time to start screening patients from weeks to days, enhancing the efficiency of clinical trials.

Yonalink provides an AI-powered platform that streams clinical trial data in real time from electronic health records (EHRs) to electronic data capture (EDC) systems, significantly reducing manual data entry and associated errors. This solution enhances data quality and operational efficiency for clinical trial sponsors, contract research organizations (CROs), and hospitals by automating data transfer and management processes.

Datacubed Health provides a platform for electronic clinical outcomes assessments (eCOA) that enhances patient engagement through a mobile-friendly application designed for clinical trials. By utilizing behavioral science principles, the platform improves data collection accuracy and patient retention, addressing challenges in participant compliance and engagement across traditional, hybrid, and decentralized trial formats.

Akrivia Health utilizes AI-powered natural language processing to analyze the world's largest dataset of de-identified psychiatric records, facilitating real-world evidence generation and clinical trial optimization for mental health and dementia research. By improving patient recruitment and study feasibility, the platform addresses the high costs and lengthy timelines associated with clinical trials in these critical areas.

The startup operates a clinical research healthcare company that provides approved treatments and disease detection services while conducting clinical trials. By facilitating access to professional medical care, it addresses the need for inclusive healthcare solutions for patients facing harmful diseases.

iLoF utilizes a cloud-based platform that employs photonics and AI to create a digital library of optical fingerprints for non-invasive patient screening and stratification in clinical trials. This technology reduces screening time by 70% and costs by 40%, while providing a more qualified pool of candidates for drug development.

The startup operates an independent Site Management Organization that conducts clinical trials by identifying, recruiting, and retaining patients at dedicated research sites. This service enables Contract Research Organizations and pharmaceutical companies to efficiently match patients with appropriate trials across various therapeutic areas.

Beacon utilizes an EEG neurobiomarker platform powered by machine learning to enhance clinical trial efficiency and optimize treatment strategies for neurological and psychiatric disorders. By providing quantitative assessments of brain activity, the platform enables precise dose selection and patient stratification, improving the likelihood of successful treatment outcomes.

This startup develops AI-powered digital twins of patients to simulate drug effects and optimize clinical trials. Their platform uses machine learning to identify effective treatments for specific diseases, accelerating drug discovery and development.

Auxilius offers clinical trial financial management software specifically designed for biopharma, enabling teams to manage study budgets, forecasts, and accruals with data-driven insights. The platform replaces traditional spreadsheet methods, enhancing financial accuracy and compliance while streamlining the financial close process for clinical research.

Quris offers a Bio-AI Clinical Prediction Platform that utilizes machine learning trained on miniaturized Patients-on-a-Chip to predict the safety of drug candidates in humans. This approach aims to reduce the high failure rate of clinical trials, which currently sees 89% of drugs not making it to market, thereby lowering development costs.

uMed utilizes the ACCESS Research Platform to automate the clinical studies process by creating consented patient cohorts and integrating electronic health records with real-time clinical outcomes. This approach addresses the challenges of slow patient enrollment and limited access to diverse populations in clinical research, enabling faster and more representative studies.

Slope.io provides Biospecimen360™, a software solution for end-to-end biospecimen lifecycle management that captures sample metadata in real-time and coordinates logistics, processing, and tracking. The platform addresses inventory shortages and compliance issues in clinical trials, enabling faster decision-making and improved data quality for sponsors and research sites.

Beaconcure offers Verify, an automated solution utilizing machine learning and natural language processing for the validation of clinical trial statistical outputs. This technology enhances data accuracy and accelerates regulatory approval processes, enabling faster market entry for new drugs and vaccines.

Contract Network develops an AI-powered collaborative platform for clinical trial agreements, enabling stakeholders to streamline negotiations and reduce contract processing time by up to 80%. By centralizing compliance and critical terms from the first draft, the platform enhances transparency and efficiency, minimizing reliance on lengthy email exchanges.

Medeloop provides an AI-powered platform designed to streamline life sciences and healthcare research workflows. The platform utilizes specialized AI agents to automate tasks across study management, complex data analytics without coding, and grant proposal generation. This accelerates the research lifecycle, enabling faster hypothesis testing and funding acquisition for researchers.

myTomorrows is a global platform that connects patients with unmet medical needs to clinical trials and treatments in development, utilizing personalized patient navigation and advanced search technology. The platform addresses the challenge of accessing timely treatment options by providing patients and healthcare professionals with streamlined resources and support for clinical trial enrollment and expanded access programs.

EmVenio Research establishes decentralized clinical trial sites in underserved communities, utilizing community engagement and data analytics to enhance patient recruitment and retention. This approach addresses the lack of access to clinical trials for diverse populations, improving enrollment rates and ensuring that underrepresented groups are included in medical research.

Altis utilizes AI models trained on the world's largest cancer imaging database to predict drug efficacy from CT scans, enhancing the accuracy of patient outcome forecasts. This technology accelerates clinical trial processes for biopharma companies by providing actionable insights into imaging data.

Humaneva provides clinical research data and insights to the medical community, enabling evidence-based decision-making and advancements in healthcare. They focus on delivering reliable data to support medical research and development.

Rune Labs develops a software platform that integrates with neuromodulation therapies to collect and analyze real-world data from patients with neurodegenerative diseases, particularly Parkinson's. This technology enables clinicians to access personalized patient data and supports life sciences companies in expediting therapy development through enhanced clinical trial processes.

Median Technologies offers the iCRO platform, an end‑to‑end imaging solution for oncology clinical trials that automates acquisition, de‑identification, storage and AI‑driven quantitative biomarker extraction from CT, MRI and PET scans to accelerate response assessment and regulatory reporting. The company also provides eyonis®, an AI/ML‑powered SaMD suite for computer‑assisted detection and diagnosis of early‑stage lung and liver cancers, delivering validated CADe/CADx performance through DICOM and HL7/FHIR integration. Both products are CE‑marked and FDA‑cleared, targeting pharma/biotech sponsors, CROs and radiology departments seeking scalable, compliant imaging analytics.

Dyania Health utilizes natural language processing to automate the review of electronic medical records (EMRs), enabling rapid pre-screening of patients for clinical trials with over 95% accuracy. This technology significantly reduces the time required for medical professionals to identify eligible candidates, ensuring timely access to critical treatments and improving patient outcomes.

Ingenix provides a multimodal generative AI platform that builds digital twins of drug candidates by integrating genomics, proteomics, imaging, literature, and electronic health records across molecular to population scales. The system delivers detailed, interpretable predictions of clinical efficacy, safety endpoints, and adverse events, and supports natural‑language “what‑if” queries for trial design and candidate prioritization. It is aimed at pre‑clinical, strategic R&D, and clinical development teams in pharmaceutical and biotechnology companies.

Amalgam Rx develops an AI-powered platform that integrates clinical and behavioral interventions into electronic health records (EHR) to enhance patient engagement and streamline provider workflows. The company addresses the need for effective patient support and clinical trial recruitment by delivering regulated software solutions that improve healthcare decision-making for patients and providers.

Theremia develops advanced digital therapeutics designed to treat neurological and psychiatric disorders through personalized, non-invasive neuromodulation. The platform utilizes proprietary algorithms to deliver precise electrical stimulation, optimizing patient outcomes for conditions like depression and chronic pain. This approach offers a scalable, accessible alternative to traditional pharmacological interventions in mental healthcare.

People Science is a technology-enabled clinical research platform that utilizes data collection tools to conduct rigorous studies on alternative medicines and wellness interventions. The platform empowers consumers to explore personalized health solutions while providing companies with reliable scientific evidence to enhance their product development.